Logo image of NVRI

ENVIRI CORP (NVRI) Stock Fundamental Analysis

NYSE:NVRI - New York Stock Exchange, Inc. - US4158641070 - Common Stock - Currency: USD

8.6  -0.4 (-4.44%)

After market: 8.6 0 (0%)

Fundamental Rating

2

Overall NVRI gets a fundamental rating of 2 out of 10. We evaluated NVRI against 83 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of NVRI have multiple concerns. NVRI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NVRI had negative earnings in the past year.
NVRI had a positive operating cash flow in the past year.
NVRI had negative earnings in each of the past 5 years.
NVRI had a positive operating cash flow in each of the past 5 years.
NVRI Yearly Net Income VS EBIT VS OCF VS FCFNVRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

NVRI has a worse Return On Assets (-4.59%) than 63.86% of its industry peers.
NVRI's Return On Equity of -30.18% is on the low side compared to the rest of the industry. NVRI is outperformed by 73.49% of its industry peers.
The Return On Invested Capital of NVRI (2.88%) is comparable to the rest of the industry.
NVRI had an Average Return On Invested Capital over the past 3 years of 2.87%. This is significantly below the industry average of 11.53%.
The 3 year average ROIC (2.87%) for NVRI is below the current ROIC(2.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4.59%
ROE -30.18%
ROIC 2.88%
ROA(3y)-4.77%
ROA(5y)-3.06%
ROE(3y)-26.4%
ROE(5y)-16.72%
ROIC(3y)2.87%
ROIC(5y)2.63%
NVRI Yearly ROA, ROE, ROICNVRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

NVRI's Operating Margin of 3.39% is in line compared to the rest of the industry. NVRI outperforms 43.37% of its industry peers.
NVRI's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 19.32%, NVRI is not doing good in the industry: 74.70% of the companies in the same industry are doing better.
NVRI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.39%
PM (TTM) N/A
GM 19.32%
OM growth 3Y-11.02%
OM growth 5Y-12.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1%
GM growth 5Y-3.78%
NVRI Yearly Profit, Operating, Gross MarginsNVRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NVRI is destroying value.
NVRI has more shares outstanding than it did 1 year ago.
NVRI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NVRI is higher compared to a year ago.
NVRI Yearly Shares OutstandingNVRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NVRI Yearly Total Debt VS Total AssetsNVRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

NVRI has an Altman-Z score of 1.93. This is not the best score and indicates that NVRI is in the grey zone with still only limited risk for bankruptcy at the moment.
NVRI has a Altman-Z score (1.93) which is comparable to the rest of the industry.
A Debt/Equity ratio of 3.55 is on the high side and indicates that NVRI has dependencies on debt financing.
NVRI has a worse Debt to Equity ratio (3.55) than 81.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.55
Debt/FCF N/A
Altman-Z 1.93
ROIC/WACC0.35
WACC8.18%
NVRI Yearly LT Debt VS Equity VS FCFNVRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

NVRI has a Current Ratio of 1.28. This is a normal value and indicates that NVRI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.28, NVRI is doing worse than 69.88% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that NVRI may have some problems paying its short term obligations.
NVRI's Quick ratio of 0.94 is on the low side compared to the rest of the industry. NVRI is outperformed by 71.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.94
NVRI Yearly Current Assets VS Current LiabilitesNVRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for NVRI have decreased strongly by -425.00% in the last year.
The Revenue has been growing slightly by 5.37% in the past year.
NVRI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.23% yearly.
EPS 1Y (TTM)-425%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
Revenue 1Y (TTM)5.37%
Revenue growth 3Y8.22%
Revenue growth 5Y14.23%
Sales Q2Q%-8.67%

3.2 Future

NVRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 98.87% yearly.
NVRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.49% yearly.
EPS Next Y-211.66%
EPS Next 2Y95.28%
EPS Next 3Y98.87%
EPS Next 5YN/A
Revenue Next Year-2.78%
Revenue Next 2Y0.41%
Revenue Next 3Y1.3%
Revenue Next 5Y2.49%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NVRI Yearly Revenue VS EstimatesNVRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
NVRI Yearly EPS VS EstimatesNVRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVRI. In the last year negative earnings were reported.
NVRI is valuated quite expensively with a Price/Forward Earnings ratio of 79.04.
The rest of the industry has a similar Price/Forward Earnings ratio as NVRI.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, NVRI is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 79.04
NVRI Price Earnings VS Forward Price EarningsNVRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NVRI indicates a somewhat cheap valuation: NVRI is cheaper than 77.11% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.14
NVRI Per share dataNVRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as NVRI's earnings are expected to grow with 98.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y95.28%
EPS Next 3Y98.87%

0

5. Dividend

5.1 Amount

No dividends for NVRI!.
Industry RankSector Rank
Dividend Yield N/A

ENVIRI CORP

NYSE:NVRI (8/1/2025, 8:04:01 PM)

After market: 8.6 0 (0%)

8.6

-0.4 (-4.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners97.44%
Inst Owner ChangeN/A
Ins Owners3.52%
Ins Owner Change16.36%
Market Cap692.30M
Analysts77.78
Price Target14.62 (70%)
Short Float %7.76%
Short Ratio9.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.51%
Min EPS beat(2)17.28%
Max EPS beat(2)61.74%
EPS beat(4)3
Avg EPS beat(4)114.02%
Min EPS beat(4)-115.08%
Max EPS beat(4)492.16%
EPS beat(8)7
Avg EPS beat(8)112.71%
EPS beat(12)11
Avg EPS beat(12)126.94%
EPS beat(16)13
Avg EPS beat(16)99.14%
Revenue beat(2)0
Avg Revenue beat(2)-4.7%
Min Revenue beat(2)-5.39%
Max Revenue beat(2)-4.01%
Revenue beat(4)0
Avg Revenue beat(4)-5.2%
Min Revenue beat(4)-8.35%
Max Revenue beat(4)-3.06%
Revenue beat(8)4
Avg Revenue beat(8)0.48%
Revenue beat(12)7
Avg Revenue beat(12)1%
Revenue beat(16)7
Avg Revenue beat(16)-5.08%
PT rev (1m)0%
PT rev (3m)1.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-94.74%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 79.04
P/S 0.3
P/FCF N/A
P/OCF 8.31
P/B 1.69
P/tB N/A
EV/EBITDA 8.14
EPS(TTM)-0.21
EYN/A
EPS(NY)0.11
Fwd EY1.27%
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)1.03
OCFY12.03%
SpS28.45
BVpS5.08
TBVpS-7.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.59%
ROE -30.18%
ROCE 3.66%
ROIC 2.88%
ROICexc 3.02%
ROICexgc 6.21%
OM 3.39%
PM (TTM) N/A
GM 19.32%
FCFM N/A
ROA(3y)-4.77%
ROA(5y)-3.06%
ROE(3y)-26.4%
ROE(5y)-16.72%
ROIC(3y)2.87%
ROIC(5y)2.63%
ROICexc(3y)3.01%
ROICexc(5y)2.75%
ROICexgc(3y)6.33%
ROICexgc(5y)5.89%
ROCE(3y)3.66%
ROCE(5y)3.35%
ROICexcg growth 3Y0.32%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y1.95%
ROICexc growth 5Y-1.33%
OM growth 3Y-11.02%
OM growth 5Y-12.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1%
GM growth 5Y-3.78%
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 3.55
Debt/FCF N/A
Debt/EBITDA 5.66
Cap/Depr 74.25%
Cap/Sales 5.79%
Interest Coverage 250
Cash Conversion 32.53%
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 0.94
Altman-Z 1.93
F-Score3
WACC8.18%
ROIC/WACC0.35
Cap/Depr(3y)80.65%
Cap/Depr(5y)82.53%
Cap/Sales(3y)6.35%
Cap/Sales(5y)7.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-425%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
EPS Next Y-211.66%
EPS Next 2Y95.28%
EPS Next 3Y98.87%
EPS Next 5YN/A
Revenue 1Y (TTM)5.37%
Revenue growth 3Y8.22%
Revenue growth 5Y14.23%
Sales Q2Q%-8.67%
Revenue Next Year-2.78%
Revenue Next 2Y0.41%
Revenue Next 3Y1.3%
Revenue Next 5Y2.49%
EBIT growth 1Y-43.91%
EBIT growth 3Y-3.7%
EBIT growth 5Y0.27%
EBIT Next Year139.25%
EBIT Next 3Y40.37%
EBIT Next 5Y25.03%
FCF growth 1Y-151.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.42%
OCF growth 3Y2.64%
OCF growth 5YN/A